US Stock MarketDetailed Quotes

AMRX Amneal Pharmaceuticals

Watchlist
  • 8.460
  • -0.190-2.20%
Close Oct 7 16:00 ET
  • 8.460
  • 0.0000.00%
Post 16:20 ET
2.62BMarket Cap-10708P/E (TTM)

Amneal Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
17.15%701.78M
18.23%659.19M
8.20%2.39B
1.18%616.98M
13.65%620.04M
7.10%599.05M
12.04%557.54M
5.67%2.21B
13.57%609.76M
3.21%545.56M
Operating revenue
17.15%701.78M
18.23%659.19M
8.20%2.39B
1.18%616.98M
13.65%620.04M
7.10%599.05M
12.04%557.54M
5.67%2.21B
13.57%609.76M
3.21%545.56M
Cost of revenue
19.21%451.83M
11.01%421.13M
10.19%1.57B
8.31%427.15M
10.30%387.51M
5.63%379.03M
17.42%379.35M
7.77%1.43B
6.44%394.37M
6.44%351.33M
Gross profit
13.60%249.95M
33.60%238.06M
4.57%820.57M
-11.87%189.83M
19.72%232.53M
9.73%220.02M
2.07%178.19M
2.05%784.71M
29.44%215.39M
-2.16%194.23M
Operating expense
15.49%167M
9.01%154.83M
0.09%596.32M
8.06%155.57M
3.29%155.34M
-3.08%144.61M
-6.70%142.03M
3.60%595.79M
-4.18%143.96M
5.95%150.4M
Selling and administrative expenses
10.32%116.46M
10.28%112.6M
7.50%429.68M
6.70%109M
12.93%113.01M
6.85%105.57M
3.48%102.1M
9.36%399.7M
5.07%102.16M
9.49%100.07M
Research and development costs
-3.94%37.1M
-0.13%40.28M
-16.13%167.78M
7.62%46.56M
-18.17%42.26M
-25.11%38.62M
-24.70%40.33M
-4.54%200.05M
-18.39%43.27M
2.16%51.65M
Other taxes
3,219.51%13.44M
135.84%1.95M
----
----
----
--405K
--826K
----
----
----
Other operating expenses
----
----
71.26%-1.14M
--0
105.53%73K
101.11%13K
---1.22M
---3.96M
---1.47M
---1.32M
Operating profit
9.99%82.95M
130.22%83.24M
18.70%224.25M
-52.03%34.26M
76.10%77.19M
46.95%75.41M
61.81%36.15M
-2.57%188.92M
341.94%71.43M
-22.50%43.83M
Net non-operating interest income expense
-29.22%-65.72M
-33.23%-65.7M
-58.47%-251.43M
-112.08%-100.35M
-20.09%-50.91M
-42.76%-50.86M
-47.94%-49.32M
-16.39%-158.67M
-39.35%-47.32M
-23.23%-42.39M
Non-operating interest expense
29.22%65.72M
33.23%65.7M
32.99%210.63M
26.62%59.55M
20.09%50.91M
42.76%50.86M
47.94%49.32M
16.18%158.38M
38.49%47.03M
23.23%42.39M
Total other finance cost
----
----
13,922.34%40.81M
----
----
----
----
--291K
----
----
Other net income (expense)
-37.70%3.18M
-2,591.41%-93.05M
95.30%-13.09M
45.32%-17.37M
-550.54%-3.33M
102.05%5.1M
249.07%3.74M
-961.91%-278.38M
-2,251.90%-31.76M
103.05%738K
Gain on sale of security
-162.23%-262K
-162.97%-1.2M
115.99%1.67M
-7.74%2.29M
46.48%-2.94M
107.75%421K
194.44%1.9M
-82.65%-10.45M
144.78%2.48M
-18,834.48%-5.49M
Special income (charges)
-121.55%-919K
-3,690.16%-95.93M
93.04%-19.88M
46.21%-20.07M
-396.73%-1.54M
101.71%4.27M
-363.37%-2.53M
-697.72%-285.76M
-9,891.34%-37.31M
101.85%520K
-Less:Restructuring and merger&acquisition
103.50%220K
-47.08%1.57M
-545.58%-12.75M
-683.52%-13.6M
617.14%4.16M
-21,562.07%-6.28M
117.36%2.97M
-71.71%2.86M
29.09%2.33M
-193.71%-805K
-Less:Other special charges
-65.34%699K
21,741.97%94.36M
-88.47%32.62M
-3.75%33.66M
-1,019.30%-2.62M
-99.19%2.02M
81.26%-436K
1,000.35%282.9M
1,699.95%34.98M
-98.95%285K
Other non- operating income (expenses)
945.56%4.36M
-6.71%4.07M
-71.29%5.12M
-86.58%411K
-79.73%1.16M
-93.99%417K
105.70%4.37M
16.33%17.83M
-53.82%3.06M
47.48%5.71M
Income before tax
-31.20%20.41M
-701.21%-75.52M
83.77%-40.27M
-990.28%-83.46M
953.07%22.96M
112.74%29.66M
4.99%-9.43M
-891.07%-248.13M
53.09%-7.66M
206.71%2.18M
Income tax
15,830.43%3.62M
821.56%6.16M
26.87%8.45M
649.97%9.88M
-145.43%-2.08M
-100.31%-23K
119.30%668K
-40.50%6.66M
-143.41%-1.8M
12.87%4.57M
Net income
-43.45%16.79M
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
1,147.41%25.03M
112.36%29.68M
-56.25%-10.09M
-1,363.21%-254.79M
71.37%-5.86M
60.77%-2.39M
Net income continuous Operations
-43.45%16.79M
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
1,147.41%25.03M
112.36%29.68M
-56.25%-10.09M
-1,363.21%-254.79M
71.37%-5.86M
60.77%-2.39M
Minority interest income
-39.25%10.79M
416.25%9.97M
128.26%35.27M
447.87%5.31M
5,034.11%15.35M
114.90%17.77M
26.79%-3.15M
-1,407.39%-124.8M
89.17%-1.53M
116.12%299K
Net income attributable to the parent company
-49.70%5.99M
-1,219.93%-91.64M
35.38%-83.99M
-2,176.69%-98.65M
460.06%9.68M
109.86%11.92M
-222.03%-6.94M
-1,323.51%-129.99M
32.05%-4.33M
36.54%-2.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-49.70%5.99M
-1,219.93%-91.64M
35.38%-83.99M
-2,176.69%-98.65M
460.06%9.68M
109.86%11.92M
-222.03%-6.94M
-1,323.51%-129.99M
32.05%-4.33M
36.54%-2.69M
Basic earnings per share
-75.00%0.02
-500.00%-0.3
44.19%-0.48
-1,233.33%-0.4
400.00%0.06
110.00%0.08
-400.00%-0.05
-1,328.57%-0.86
25.00%-0.03
33.33%-0.02
Diluted earnings per share
-75.00%0.02
-500.00%-0.3
44.19%-0.48
-1,233.33%-0.4
400.00%0.06
110.00%0.08
-400.00%-0.05
-1,328.57%-0.86
25.00%-0.03
33.33%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 17.15%701.78M18.23%659.19M8.20%2.39B1.18%616.98M13.65%620.04M7.10%599.05M12.04%557.54M5.67%2.21B13.57%609.76M3.21%545.56M
Operating revenue 17.15%701.78M18.23%659.19M8.20%2.39B1.18%616.98M13.65%620.04M7.10%599.05M12.04%557.54M5.67%2.21B13.57%609.76M3.21%545.56M
Cost of revenue 19.21%451.83M11.01%421.13M10.19%1.57B8.31%427.15M10.30%387.51M5.63%379.03M17.42%379.35M7.77%1.43B6.44%394.37M6.44%351.33M
Gross profit 13.60%249.95M33.60%238.06M4.57%820.57M-11.87%189.83M19.72%232.53M9.73%220.02M2.07%178.19M2.05%784.71M29.44%215.39M-2.16%194.23M
Operating expense 15.49%167M9.01%154.83M0.09%596.32M8.06%155.57M3.29%155.34M-3.08%144.61M-6.70%142.03M3.60%595.79M-4.18%143.96M5.95%150.4M
Selling and administrative expenses 10.32%116.46M10.28%112.6M7.50%429.68M6.70%109M12.93%113.01M6.85%105.57M3.48%102.1M9.36%399.7M5.07%102.16M9.49%100.07M
Research and development costs -3.94%37.1M-0.13%40.28M-16.13%167.78M7.62%46.56M-18.17%42.26M-25.11%38.62M-24.70%40.33M-4.54%200.05M-18.39%43.27M2.16%51.65M
Other taxes 3,219.51%13.44M135.84%1.95M--------------405K--826K------------
Other operating expenses --------71.26%-1.14M--0105.53%73K101.11%13K---1.22M---3.96M---1.47M---1.32M
Operating profit 9.99%82.95M130.22%83.24M18.70%224.25M-52.03%34.26M76.10%77.19M46.95%75.41M61.81%36.15M-2.57%188.92M341.94%71.43M-22.50%43.83M
Net non-operating interest income expense -29.22%-65.72M-33.23%-65.7M-58.47%-251.43M-112.08%-100.35M-20.09%-50.91M-42.76%-50.86M-47.94%-49.32M-16.39%-158.67M-39.35%-47.32M-23.23%-42.39M
Non-operating interest expense 29.22%65.72M33.23%65.7M32.99%210.63M26.62%59.55M20.09%50.91M42.76%50.86M47.94%49.32M16.18%158.38M38.49%47.03M23.23%42.39M
Total other finance cost --------13,922.34%40.81M------------------291K--------
Other net income (expense) -37.70%3.18M-2,591.41%-93.05M95.30%-13.09M45.32%-17.37M-550.54%-3.33M102.05%5.1M249.07%3.74M-961.91%-278.38M-2,251.90%-31.76M103.05%738K
Gain on sale of security -162.23%-262K-162.97%-1.2M115.99%1.67M-7.74%2.29M46.48%-2.94M107.75%421K194.44%1.9M-82.65%-10.45M144.78%2.48M-18,834.48%-5.49M
Special income (charges) -121.55%-919K-3,690.16%-95.93M93.04%-19.88M46.21%-20.07M-396.73%-1.54M101.71%4.27M-363.37%-2.53M-697.72%-285.76M-9,891.34%-37.31M101.85%520K
-Less:Restructuring and merger&acquisition 103.50%220K-47.08%1.57M-545.58%-12.75M-683.52%-13.6M617.14%4.16M-21,562.07%-6.28M117.36%2.97M-71.71%2.86M29.09%2.33M-193.71%-805K
-Less:Other special charges -65.34%699K21,741.97%94.36M-88.47%32.62M-3.75%33.66M-1,019.30%-2.62M-99.19%2.02M81.26%-436K1,000.35%282.9M1,699.95%34.98M-98.95%285K
Other non- operating income (expenses) 945.56%4.36M-6.71%4.07M-71.29%5.12M-86.58%411K-79.73%1.16M-93.99%417K105.70%4.37M16.33%17.83M-53.82%3.06M47.48%5.71M
Income before tax -31.20%20.41M-701.21%-75.52M83.77%-40.27M-990.28%-83.46M953.07%22.96M112.74%29.66M4.99%-9.43M-891.07%-248.13M53.09%-7.66M206.71%2.18M
Income tax 15,830.43%3.62M821.56%6.16M26.87%8.45M649.97%9.88M-145.43%-2.08M-100.31%-23K119.30%668K-40.50%6.66M-143.41%-1.8M12.87%4.57M
Net income -43.45%16.79M-709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M1,147.41%25.03M112.36%29.68M-56.25%-10.09M-1,363.21%-254.79M71.37%-5.86M60.77%-2.39M
Net income continuous Operations -43.45%16.79M-709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M1,147.41%25.03M112.36%29.68M-56.25%-10.09M-1,363.21%-254.79M71.37%-5.86M60.77%-2.39M
Minority interest income -39.25%10.79M416.25%9.97M128.26%35.27M447.87%5.31M5,034.11%15.35M114.90%17.77M26.79%-3.15M-1,407.39%-124.8M89.17%-1.53M116.12%299K
Net income attributable to the parent company -49.70%5.99M-1,219.93%-91.64M35.38%-83.99M-2,176.69%-98.65M460.06%9.68M109.86%11.92M-222.03%-6.94M-1,323.51%-129.99M32.05%-4.33M36.54%-2.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -49.70%5.99M-1,219.93%-91.64M35.38%-83.99M-2,176.69%-98.65M460.06%9.68M109.86%11.92M-222.03%-6.94M-1,323.51%-129.99M32.05%-4.33M36.54%-2.69M
Basic earnings per share -75.00%0.02-500.00%-0.344.19%-0.48-1,233.33%-0.4400.00%0.06110.00%0.08-400.00%-0.05-1,328.57%-0.8625.00%-0.0333.33%-0.02
Diluted earnings per share -75.00%0.02-500.00%-0.344.19%-0.48-1,233.33%-0.4400.00%0.06110.00%0.08-400.00%-0.05-1,328.57%-0.8625.00%-0.0333.33%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data